Following cerebral ischemia, a smaller infarct volume was produced in myeloid cell MR-deficient mice compared with control mice, consistent with MR-expressing circulating immune cells mediating post-ischemic neuronal injury[25]. The gene discussed is NR3C2; the disease is Cerebral ischemia.